proline has been researched along with ethinyl estradiol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cleuren, AC; Reitsma, PH; Spronk, HM; Van Oerle, R; Van Vlijmen, BJ | 1 |
| Butterton, JR; Feng, HP; Lin, WH; O'Reilly, T; Shadle, CR; Wagner, JA | 1 |
| Elgadi, M; Huang, F; Lang, B; Sabo, JP | 1 |
| Alam, N; Angeli, MG; Greenblatt, DJ | 1 |
| Beger, RD; Nakamura, N; Sloper, DT; Sun, J | 1 |
| Christmann, R; Naik, H; Tidemann-Miller, B; Versavel, M; Zhao, Y | 1 |
2 trial(s) available for proline and ethinyl estradiol
| Article | Year |
|---|---|
Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hepacivirus; Humans; Luteinizing Hormone; Norethindrone; Progesterone; Proline; Protease Inhibitors; Sex Hormone-Binding Globulin; Young Adult | 2014 |
Effect of the hepatitis C virus protease inhibitor faldaprevir on the pharmacokinetics of an oral contraceptive containing ethinylestradiol and levonorgestrel in healthy female volunteers.
Topics: Administration, Oral; Adolescent; Adult; Aminoisobutyric Acids; Area Under Curve; Bilirubin; Contraceptives, Oral, Combined; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Half-Life; Humans; Leucine; Levonorgestrel; Oligopeptides; Proline; Protease Inhibitors; Quinolines; Thiazoles; Viral Nonstructural Proteins; Young Adult | 2015 |
4 other study(ies) available for proline and ethinyl estradiol
| Article | Year |
|---|---|
Long-term estrogen treatment of mice with a prothrombotic phenotype induces sustained increases in thrombin generation without affecting tissue fibrin deposition.
Topics: Administration, Oral; Animals; Automation; Blood Coagulation; Estrogens; Ethinyl Estradiol; Factor V; Fibrin; Hemostasis; Mice; Mice, Inbred C57BL; Mutation; Phenotype; Proline; Thrombin; Thrombomodulin; Time Factors | 2012 |
Mechanism of in-vitro inhibition of UGT1A1 by paritaprevir.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Cyclopropanes; Drug Interactions; Enzyme Inhibitors; Ethinyl Estradiol; Glucuronosyltransferase; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Microsomes, Liver; Middle Aged; Probenecid; Proline; Sulfonamides; Young Adult | 2017 |
Metabolomics-based pathway changes in testis fragments treated with ethinylestradiol in vitro.
Topics: Animals; Arginine; Creatinine; Energy Metabolism; Ethinyl Estradiol; Male; Metabolic Networks and Pathways; Metabolome; Metabolomics; Mice, Inbred C57BL; Proline; Testis | 2019 |
Evaluation of the Potential Pharmacokinetic Interactions Between Vixotrigine and an Oral Contraceptive.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Phenyl Ethers; Proline; Young Adult | 2020 |